Trial Profile
A Phase 1, Randomized, Open-Label, Standard Of Care Control, Dose-Escalating, Multicenter, Safety Study Of BMP-655/ACS As An Adjuvant Therapy For Treatment Of Full-Thickness Rotator Cuff Tears Treated By Means Of An Open Surgical Repair
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 08 Dec 2022
Price :
$35
*
At a glance
- Drugs BMP 655 (Primary)
- Indications Rotator cuff injuries
- Focus Adverse reactions
- Sponsors Pfizer
- 08 Dec 2022 New source identified and integrated Japan Pharmaceutical Information Center - Clinical Trials Information (JapicCTI101216)
- 08 May 2014 New trial record